Abstract |
2-Methoxyestradiol (2-ME), an endogenous metabolite of 17 beta-estradiol, is known to be a potent inhibitor of neovascularization. Our previous studies have shown that 2-ME can suppress growth of pancreatic tumor cells in vitro and in vivo by the induction of apoptosis ( Cancer Res 66: 4309-18, 2006). In order to better comprehend the signaling modulators of 2-ME in pancreatic cancer, we employed a PowerBlot Western Array screening system. Our proteomic profiling has provided framework to define the novel mechanisms of actions of 2-ME in pancreatic cancer. Interestingly, this high-throughput analysis identified proteins such as Rac1, Gelsolin, Glucocorticoid receptor (GR), Smad 2/3, Smad 4, IRS-1, which were not previously reported with 2-ME response. Interestingly, 2-ME modulated down regulation of GR level is accompanied by NF-k B activation in 2-ME responsive but not in resistant pancreatic cancer cells. In view of this observation, possible reciprocal relationship between GR and NF-kappaB activation might be an important regulatory factor in 2-ME mediated demise of a subpopulation of pancreatic cancer cells.
|
Authors | Aruna Basu, Subrata Haldar |
Journal | Frontiers in bioscience (Landmark edition)
(Front Biosci (Landmark Ed))
Vol. 14
Issue 6
Pg. 2170-80
(01 01 2009)
ISSN: 2768-6698 [Electronic] Singapore |
PMID | 19273191
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Cell Cycle Proteins
- Hypoxia-Inducible Factor 1
- NF-kappa B
- Receptors, Glucocorticoid
- Vascular Endothelial Growth Factor A
- Estradiol
- 2-Methoxyestradiol
|
Topics |
- 2-Methoxyestradiol
- Apoptosis
- Blotting, Western
- Cell Cycle Proteins
(metabolism)
- Cell Line, Tumor
- Enzyme-Linked Immunosorbent Assay
- Estradiol
(analogs & derivatives, pharmacology)
- Humans
- Hypoxia-Inducible Factor 1
(metabolism)
- NF-kappa B
(metabolism)
- Pancreatic Neoplasms
(metabolism, pathology)
- Receptors, Glucocorticoid
(metabolism)
- Signal Transduction
(drug effects)
- Vascular Endothelial Growth Factor A
(metabolism)
|